Inovio Pharmaceuticals, Inc. (INO)
NASDAQ · Healthcare
Inovio Pharmaceuticals, Inc. Total Liabilities 2009–2025
Inovio Pharmaceuticals, Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Inovio Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 50.2M, a 12.35% increase year-over-year.
- Inovio Pharmaceuticals, Inc. total liabilities for 2025 were 50.2M, a 12.35% increase from 2024.
- Inovio Pharmaceuticals, Inc. total liabilities for 2024 were 44.7M, a 16.62% decrease from 2023.
- Inovio Pharmaceuticals, Inc. total liabilities for 2023 were 53.6M, a 57.52% decrease from 2022.
- Inovio Pharmaceuticals, Inc. total liabilities for 2022 were 126.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inovio Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $50 |
| 2024 | $45 |
| 2023 | $54 |
| 2022 | $126 |
| 2021 | $96 |
| 2020 | $79 |
| 2019 | $139 |
| 2018 | $44 |
| 2017 | $45 |
| 2016 | $50 |
| 2015 | $38 |
| 2014 | $20 |
| 2013 | $35 |
| 2012 | $10 |
| 2011 | $13 |
Inovio Pharmaceuticals, Inc. Total Liabilities — FAQ
Inovio Pharmaceuticals, Inc. (INO) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INO's total liabilities history?
The chart and table above show Inovio Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.